• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Daiichi Sankyo Co Ltd

+ Add to Watchlist


11.410 EUR 0.034 0.30%

As of 02:16:02 ET on 12/22/2014.

Snapshot for Daiichi Sankyo Co Ltd (D4S)

Open: 11.394 Day's Range: 11.348 - 11.410 Volume: 0
Previous Close: 11.444 52wk Range: 11.161 - 14.110 1-Yr Rtn: -9.48%

Stock Chart for D4S

No chart data available.
  • D4S:GR 11.410
  • 1D
  • 1M
  • 1Y
Interactive D4S Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for D4S

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 17.0798
Relative P/E vs. DAX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (03/2015) 97.9140
Est. PEG Ratio 10.3514
Market Cap (M EUR) 8,089.82
Shares Outstanding (M) 709.01
30 Day Average Volume 152
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.69%
Cash Dividend (JPY) 30.0000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth -4.02%
Next Earnings Announcement 01/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for D4S

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for D4S

DAIICHI SANKYO COMPANY, LIMITED is a holding company established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals.

Joji NakayamaPresident/CEOYuki SatoExecutive Vice President
Manabu SakaiExecutive Vice PresidentTakeshi OgitaSenior Managing Exec Officer
More Company Profile & Key Executives for D4S

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil